Table 3 |
|||||||
|
Mean (SD) of groups, mean (SD) difference within groups, and mean (95% CI) difference between groups adjusting for the baseline value of the measure, for outcomes with interval data. |
|||||||
|
Outcome |
Groups |
Difference within groups |
Difference between groups* |
||||
|
|
|
|
|||||
|
Week 0 |
Week 11 |
Week 11 minus Week 0 |
Week 11 minus Week 0 |
||||
|
|
|
|
|
||||
|
Physio n = 11 |
Cont n = 9 |
Physio n = 11 |
Cont n = 9 |
Physio |
Cont |
Physiotherapy minus Control |
|
|
|
|||||||
|
Pain on movement (0-10) |
3.1 (2.7) |
2.1 (2.0) |
1.8 (2.3) |
3.1 (1.8) |
-1.3 (2.4) |
1.0 (1.4) |
-1.8 (-3.5 to -0.1) |
|
Pain on rest (0-10) |
3.0 (2.7) |
1.4 (1.8) |
1.1 (2.2) |
2.0 (2.6) |
-1.9 (2.3) |
0.6 (1.0) |
-2.0 (-3.8 to -0.2) |
|
Restriction (0-10) |
2.5 (2.0) |
2.7 (2.6) |
1.3 (2.4) |
3.2 (2.9) |
-1.2 (2.4) |
0.6 (2.0) |
-1.8 (-3.9 to 0.3) |
|
AQol (-0.04 - 1.00) |
0.51 (0.25) |
0.56 (0.14) |
0.54 (0.25) |
0.49 (0.16) |
0.03 (0.17) |
-0.08 (0.11) |
0.10 (-0.04 to 0.24) |
|
Qualeffo Total (0-100) |
29 (10) |
26 (7) |
21 (11) |
27 (8) |
-7.2 (11.2) |
1.2 (4.1) |
-7.1 (-14.9 to 0.8) |
|
Qualeffo Pain (0-100) |
51 (24) |
32 (20) |
29 (30) |
37 (19) |
-22.7 (28.8) |
5.0 (11.5) |
-19.3 (-41.5 to 3.0) |
|
Qualeffo Physical function (0-100) |
16 (8) |
15 (9) |
11 (6) |
15 (8) |
-5.4 (6.2) |
-0.2 (4.1) |
-4.8 (-9.2 to -0.5) |
|
Qualeffo Social function (0-100) |
31 (17) |
35 (12) |
23 (16) |
33 (11) |
-7.9 (13.8) |
-1.2 (4.8) |
-8.0 (-17.3 to 1.4) |
|
Qualeffo General health (0-100) |
49 (14) |
43 (13) |
39 (25) |
45 (16) |
-9.9 (20.0) |
1.9 (8.1) |
-12.1 (-27.9 to 3.7) |
|
Qualeffo Mental function (0-100) |
32 (10) |
30 (7) |
30 (13) |
32 (10) |
-1.3 (13.6) |
2.2 (7.2) |
-2.8 (-13.2 to 7.7) |
|
Thoracic kyphosis (deg) |
59 (9) |
58 (12) |
56 (10) |
58 (12) |
-3.2 (5.9) |
-0.2 (3.7) |
-2.9 (-7.9 to 2.1) |
|
Timed up and go (s) |
9.7 (2.7) |
9.8 (1.7) |
9.0 (1.5) |
9.6 (1.7) |
-0.7 (1.6) |
-0.2 (3.7) |
-0.5 (-1.6 to 0.6) |
|
Timed loaded standing test (s) |
50 (39) |
62 (49) |
82 (44) |
46 (50) |
32.6 (34.1) |
-16.7 (29.8) |
46.7 (16.1 to 77.3) |
|
|
|||||||
|
* adjusted for the baseline value of the measurement |
|||||||
|
Bennell et al. BMC Musculoskeletal Disorders 2010 11:36 doi:10.1186/1471-2474-11-36 |
|||||||